Company intelligence / Profile preview

SeaSpine

Carlsbad, California, United Stateslinkedin.com ↗

Ownership: Public · SPNE
Development stage: Commercial

Overview

SeaSpine developed a comprehensive portfolio of spinal implants and orthobiologics that are commercially available globally. Their products have demonstrated clinical utility in improving bone fusion rates in preclinical studies (e.g., OsteoStrand Plus DBM outperformed tested cellular bone matrix products). The company was recognized as a leader in demineralized bone matrix (DBM) with robust U.S. market presence.

Therapeutic areas: RheumatologyNeurology
Modalities: DeviceBiologic
Industry: Surgical Medical Devices

Partnerships

Partnership with restor3d to develop novel 3D printed interbody devicesCollaboration with surgeons via educational programs such as Coast, SeaSpine Institute & PIER.

Financials

Market cap: $0
Total revenue: $67.1M
Enterprise value: $-3.4M

Beyond the preview

Go deeper on SeaSpine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SeaSpine.

Explore the full profile